Diabetes drug muraglitazar faces major hurdle: despite a recent FDA approval letter, cardiovascular safety concerns may halt development of the drug.: … An article from: Internal Medicine News

Product Description
This digital document is an article from Internal Medicine News, published by Thomson Gale on December 1, 2005. The length of the article is 1025 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Diabetes drug muraglitazar … More >>

Diabetes drug muraglitazar faces major hurdle: despite a recent FDA approval letter, cardiovascular safety concerns may halt development of the drug.: … An article from: Internal Medicine News

Tags: approval, article, cardiovascular, concerns, despite, Development., diabetes, Drug, faces, From, halt, hurdle, Internal, letter, major, Medicine, muraglitazar, News, recent, Safety

approval, article, cardiovascular, concerns, despite, Development., diabetes, Drug, faces, From, halt, hurdle, Internal, letter, major, Medicine, muraglitazar, News, recent, Safety

This entry was posted on , and is filed under Articles. You can follow any responses to this entry through RSS 2.0. You can leave a response, or trackback from your own site.

Diabetes Treatment Guides

Diabetes drug muraglitazar faces major hurdle: despite a recent FDA approval letter, cardiovascular safety concerns may halt development of the drug.: … An article from: Internal Medicine News

Related posts

Search

Recent Posts